Filter
546
Text search:
drugs
and
related
substances
act
Featured
58
138
Language
Document type
339
78
51
34
18
14
4
3
2
2
1
Countries / Regions
37
36
31
17
17
15
15
14
12
10
10
9
9
7
7
6
6
6
5
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
245
30
24
21
12
7
7
Toolboxes
77
49
48
35
18
17
11
10
9
8
7
6
6
5
3
2
1
1
1
1
Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also st
...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-
...
Perspectives on Drugs
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-
...
Perspectives on Drugs
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time
...
Three Years After Enactment of the Drug Quality and Security Act
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
A.55 Medicines and Related Substances Act, 2013 | No. 8 of 2013 | An
...
Policy Brief, Updated in March 2017
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded
...
